Large deletions of the PRKAR1A gene in carney complex

Clinical Cancer Research

Volumn 14, Issue 2, 2008, Pages 388-395

  Horvath, Anelia ^a   Bossis, Ioannis ^a   Giatzakis, Christoforos ^a   Levine, Elizabeth ^a   Weinberg, Frank ^a   Meoli, Elise ^a   Robinson White, Audrey ^a   Siegel, Jennifer ^a   Soni, Payal ^a   Groussin, Lionel ^c   Matyakhina, Ludmila ^a   Verma, Somya ^a   Remmers, Elaine ^b   Nesterova, Maria ^a   Carney, J Aidan ^b   Bertherat, Jérôme ^c   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BASE PAIRING; CARNEY COMPLEX; CHROMOSOME 2; CHROMOSOME MAP; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EXON; FEMALE; GENE; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE SEQUENCE; GERM LINE; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PRKAR1A GENE; PROTEIN PROTEIN INTERACTION; SOUTHERN BLOTTING;

CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; EXONS; GENE DELETION; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA;

EID: 38949096090     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1155     Document Type: Article

References (22)

1. Carney JA, Hruska LS, Beauchamp GD, Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc 1986;61:165-72.
2. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001;86:4041-6.
3. Bertherat J. Carney complex (CNC). Orphanet J Rare Dis 2006;1:21.
4. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.
5. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000;9:3037-46.
6. Boikos SA, Stratakis CA. Carney complex: pathology and molecular genetics. Neuroendocrinology 2006;83:189-99.
7. Mabuchi T, Shimizu M, Ino H, et al. PRKAR1A gene mutation in patients with cardiac myxoma. Int J Cardiol 2005;102:273-7.
8. Perdigao PF, Stergiopoulos SG, De Marco L, et al. Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas. Genes Chromosomes Cancer 2005;44:204-11.
9. Urban C, Weinhausel A, Fritsch P, et al. Primary pigmented nodular adrenocortical disease (PPNAD) and pituitary adenoma in a boy with sporadic Carney complex due to a novel, de novo paternal PRKAR1A mutation (R96X). J Pediatr Endocrinol Metab 2007;20:247-52.
10. Bertherat J, Groussin L, Sandrini F, et al. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res 2003;63:5308-19.
11. Matyakhina L, Pack S, Kirschner LS, et al. Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet 2003;40:268-77.
12. Libe R, Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 2005;153:477-87.
13. Robinson-White AJ, Leitner WW, Aleem E, Kaldis P, Bossis I, Stratakis CA. PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes. Cancer Res 2006;66:10603-12.
14. Antonarakis SE, Krawczak M, Cooper DN. The nature and mechanisms of human gene mutation. In: KW VBaK, editor. The genetic basis of human cancer. New York: McGraw Hill; 2000.
15. Groussin L, Horvath A, Jullian E, et al. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 2006;91:1943-9.
16. Robinson-White A, Meoli E, Stergiopoulos S, et al. PRKAR1A mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex. J Clin Endocrinol Metab 2006;91:2380-8.
17. Bossis I, Stratakis CA. Minireview: PRKAR1A: normal and abnormal functions. Endocrinology 2004;145:5452-8.
18. Stratakis CA. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex). Ann N Y Acad Sci 2002;968:3-21.
19. Hamuro Y, Anand GS, Kim JS, et al. Mapping intersubunit interactions of the regulatory subunit (RIα) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS). J Mol Biol 2004;340:1185-96.
20. Kim C, Xuong NH, Taylor SS. Crystal structure of a complex between the catalytic and regulatory (RIα) subunits of PKA. Science 2005;307:690-6.
21. Martin-Reay DG, Shattuck MC, Guthrie FW, Jr. Psammomatous melanotic schwannoma: an additional component of Carney's complex. Report of a case. Am J Clin Pathol 1991;95:484-9.
22. Samdarshi TE, Mahan EF III, Nanda NC, Guthrie FW, Jr., Bernstein IJ, Kirklin JW. Transesophageal echocardiographic diagnosis of multicentric left ventricular myxomas mimicking a left atrial tumor. J Thorac Cardiovasc Surg 1992;103:471-4.